Assembly Biosciences ASMB
NASDAQ ASMB
$22.98 -0.51 (-2.17%)
At close: Oct 1, 2026 · 4:00 PM EDT

Assembly Biosciences (ASMB) Non Operating Income (2011 - 2026)

Updated

Assembly Biosciences (ASMB) recorded Non Operating Income of $2.49 million in Q2 2026, up 177.9% from $895,000 a year earlier and up 8.6% from the prior quarter.

Analysis

Assembly Biosciences (ASMB) Non Operating Income (2011 - 2026) Analysis & Trends

On a TTM basis, Assembly Biosciences' Non Operating Income came in at $8.76 million as of Jun 30, 2026, up 95.4% year-over-year; for FY2025, it came in at $6 million, up 7.6% from FY2024.

  • Annual Non Operating Income has increased for four straight years, with a five-year compound annual growth rate of 18.0% (FY2020 to FY2025).
  • Across earlier years, Non Operating Income came in at $5.57 million in FY2024 (+61.5%), $3.45 million in FY2023 (+237.7%), $1.02 million in FY2022 (+238.4%) and $302,000 in FY2021 (-88.5%).
  • The Q2 2026 figure is the highest quarterly Non Operating Income in data going back to Q1 2011.
  • On a year-over-year basis, Non Operating Income has increased for four consecutive quarters, with growth averaging 53.0% over the last eight quarters.
  • Peak year-over-year performance for Non Operating Income in the last five years was growth of 757.7% in Q1 2023, against a decline of 89.3% in Q3 2021 at the low end.
  • Per Business Quant, the preceding three quarters came in at $2.29 million (Q1 2026), $2.29 million (Q4 2025) and $1.69 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Assembly Biosciences 466.28 Mn -561.34 Mn - 2.49 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.49 Mn
Mar 31, 2026 2.29 Mn
Dec 31, 2025 2.29 Mn
Sep 30, 2025 1.69 Mn
Jun 30, 2025 895,000.00
Mar 31, 2025 1.12 Mn
Dec 31, 2024 1.12 Mn
Sep 30, 2024 1.34 Mn
Jun 30, 2024 1.46 Mn
Mar 31, 2024 1.65 Mn
Dec 31, 2023 1.62 Mn
Sep 30, 2023 628,000.00
Jun 30, 2023 592,000.00
Mar 31, 2023 609,000.00
Dec 31, 2022 583,000.00
Sep 30, 2022 256,000.00
Jun 30, 2022 112,000.00
Mar 31, 2022 71,000.00
Dec 31, 2021 101,000.00
Sep 30, 2021 72,000.00
API Access

Assembly Biosciences Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=ASMB&period=max&api_key=YOUR_API_KEY